Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT05817058
Status:
TERMINATED
Last Update Posted:
2025-07-23
First Post:
2023-03-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor:
Affimed GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-13
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-22
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-18
Last Update Post Date:
2025-07-23
Last Update Post Date Type:
ACTUAL